Friday, August 29, 2014

In race for bigger margins, drug makers willing to lose the India "advantage"

By Zeba Siddiqui
MUMBAI (Reuters) - Indian drugmakers are fleeing a regulatory morass at home and moving some research and development to Europe and the United States as try to boost margins by producing high-value drugs.
India's $15 billion a year pharma industry, the world's largest source of cheap generics, is already reeling from a string of drug recalls and quality control issues which have called into question the regulator's oversight.
Now, companies like Piramal Enterprises Ltd, Sun Pharmaceutical Industries Ltd and Lupin Ltd are investing millions of dollars and placing their future growth in foreign regulators' hands, as they seek to add more complex drugs to their product lines.
"We have lost what is called the India advantage," said Swati Piramal, vice-chair of Mumbai-based Piramal Enterprises which last year moved some clinical trials for new drugs abroad.
"The India advantage was saying we can research molecules...and finish the clinical trials and the cost would be one-tenth of the West," she said.
"Now, we have to acquire small groups of highly specialised people who can work on a particular type of product and know exactly how to do it. That's the new alternative - to really invest in R&D abroad," she added.
Indian drugmakers rely on cheap generics for the bulk of their revenue, but like their global peers, they are focusing more on niche markets such as ophthalmology and oral contraceptives, and difficult-to-make products such as inhalers and injectables in a bid to achieve higher profit margins.

continue to read here

Autopsy doesn't say why Oklahoma inmate writhed - WSMV Channel 4

Autopsy doesn't say why Oklahoma inmate writhed - WSMV Channel 4

Review; Comment Request; Guidance for Industry on Fees for Human Drug Compounding. Outsourcing Facilities

Docket No. FDA-2014-D-0329 - The Office of the Federal ...

www.ofr.gov/(S(4mu01etsd4epjrevv0iippia))/.../2014-20719_PI.pdf
27 mins ago - Review; Comment Request; Guidance for Industry on Fees for Human Drug Compounding. Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic ...

Thursday, August 28, 2014

More information on Dan Milosvic

Overview of Dan Milosevic in Houston, TX

Dan Milosevic is the Office Manager of Pain & Health Management Center Inc and inactive roles in one additional company .
Dan Milosevic is connected to other officers through these corporate roles. One of the top connections is Charmaine Kray .
Dan's past corporate interests include the Manager of Texas Pain Consultants .
view chart here

 

 

Records Similar to Dan Milosevic

Question of the Day August 28, 2014 Is the Dan Milosevic who is the President of Alternative Medicine and Pharmacy Inc. d/b/a/ OmniPlus Pharmacy and who verified the complaint against Express Scripts the same person who started Medical Billing and Consulting Services in Houston, Texas?

Dan Milosevic started Medical Billing and Consulting Services in Houston, TX, after working as a consultant in billing and practice management for a solo practitioner. Dan was so effective—he doubled his client’s monthly revenue—that his client began talking about him to other practitioners. That was when he decided to establish Medical Billing and Consulting Services. “I felt I could offer the same level of service and efficiency to other providers,” he states. That was in 2007and five years later, his company is growing stronger each year.

We specialize in pain management,” Dan declares. “Because of our experience in billing for this specialty, we are able to bring in 30 - 40 percent more revenue than other companies that handle multiple specialties.” Dan has four employees working on behalf of his four clients and they bill $1.2 million in charges per month with a net collection ratio around 95%. He plans to leverage his expertise in pain management billing for attracting new clients within the specialty of anesthesia.
“When I opened my company, the most important decision we had to make was picking the right medical billing software,” Dan notes. He knew what he wanted in a software solution and looked at numerous systems before selecting Kareo. “It met all our criteria then and it continues to meet our expectations,” he says. “It is an online system, so you can access it from anywhere in the world as long as you have an Internet connection. It’s very easy to set up, learn and run. It offers electronic eligibility, electronic claims submission to almost all payors, very advanced reporting capabilities and a scheduling system.” Dan says Kareo’s outstanding support sets it apart from other systems. “Many times, you can resolve any issues you may have using Kareo’s free online tools, like the support library with numerous solutions for different problems, and the FAQs. I have been on Kareo for five years and in all that time, I have never had to call their technical support team!”
Dan appreciates the fact that Kareo is very user friendly on many levels. “You can set new clients up on Kareo in just minutes. I’ve used a lot of other system and Kareo is by far the simplest to use. Our clients love Kareo and the fact that all they need is a computer and internet access. Basically, once they are set up on Kareo, they can start scheduling patients right away.” The outstanding support is as big a plus for clients as it is for Dan and his employees. “Kareo offers useful videos so if you have a problem, you just find the appropriate video and your problem is solved!” That is a real timesaver when clients have an issue they want to resolve right away, Dan says, since they have no qualms about using Kareo’s easy-to-access tools to find the answer they need.
Another useful feature, according to Dan, is electronic eligibility. He says it saves his staff time and increases their productivity. “With other systems, you need to visit multiple websites to check a patient’s insurance eligibility and verify their benefits,” he notes. “With Kareo you can do that with the click of a button, right from within the software! In five or ten seconds, you know all about a patient’s benefits. That saves at least five minutes and if you are working on billing for 20 patients, that means you’re saving over an hour and a half!”
Dan says Kareo’s scalability will easily allow him to double his client base, as he plans to do in 2012. “Kareo helped us to increase our productivity and profitability, while at the same time decreased our costs by more than 30 percent. Overall, I would say that selecting Kareo is one of our best business decisions.”

quoted from here

Original Source: Stability of compounded thioguanine oral suspensions.

Purpose Updated information on the stability of compounded thioguanine oral suspensions prepared with currently available ingredients, as well as results of testing to determine if the addition of an antioxidant could extend shelf life by inhibiting formation of guanine, are presented. Methods Using triturated thioguanine tablets, three compounded suspensions were prepared: (1) a reference formulation containing methylcellulose and simple syrup, (2) an equivalent formulation using Ora-Plus and Ora-Sweet, an...

continue to read here

Pharmacist Hootan Melamed Previously Charges with Fraud

Texas Board of Pharmacy Disciplinary Action for September 2013 -February 2014

Interesting and Important Comments from Readers Being Posted

"Breaking News: Concierge Compounding Pharmaceuticals Inc. v. Express Scripts Inc.: A Lawsuit seeking to Stop Express Script from Terminating a Compounding Pharmacy from its Network-hearing set for tomorrow August 29, 2014"

3 Comments - Show Original Post Collapse comments


1 – 3 of 3
Anonymous Anonymous said...
Is this the pharmacy with registration hurdle in Idaho due to felony charge? See: http://bop.idaho.gov/board_meeting/2013-08-13and14_Minutes_Final_01-09-2014.pdf
August 28, 2014 at 10:15 AM
Delete
Anonymous Anonymous said...
Very very interesting case developing here. If chemical ingredients for mixing up largely experimental compounded drugs hold separate NDCs and are covered under tier II, separate co-pays should be required for each ingredient? Otherwise, pharmacies could compound multiple active ingredients in one dosage form for the sole purpose of avoiding co-pays, particularly if the AWPs for the ingredients are sufficiently inflated?
Hard to believe I just used the acronym AWP and chemical ingredient the same sentence--in the grand American tradition, this is compounding "super-sized."
August 28, 2014 at 10:28 AM
Delete
Anonymous Anonymous said...
The co-pay issue is in the self interest of the payer, i.e., controlling over utilization, but, there are other more troubling patient safety and supply chain security concerns related to paying for ingredients, versus finished pharmaceuticals.
Thinking in high-level marketing sound bites, it all sounds really good--the doctor orders a customized drug when a patient cannot use an FDA-approved product, partly the result of industry failing to invest in small market needs.
But if you scratch below the surface, there is a lot of missing information--does the doctor or insurer consider that the formulas haven't been evaluated for safety and efficacy? Even more troubling may be the chemical ingredients themselves--these white powders in jars, having traveled through global supply channels, may come with "certificates of analysis," that, at the high level marketing sound bite, sound really good too. But, displayed results may exclude criteria relevant to the dosage form made (residual solvents, microbial content), and for the criteria that are listed, the stated results may not be guaranteed by the seller. How does this white powder in a jar become a tier ii level Rx product?
You can't distill this level of necessary problem-solving, albeit for a sometimes necessary pharmacy practice, into a soundbite.
August 28, 2014 at 12:29 PM
Delete

More Breaking News: Another Lawsuit OmniPlus Pharmacy from Texas suing Express Scripts--Here is the docket/Documents are available on Pacer

Date Filed#Docket Text
08/25/20141 COMPLAINT against defendant All Defendants with receipt number 0865-4464876, in the amount of $400 Jury Demand,, filed by Alternative Medicine and Pharmacy, Inc. . (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet, # 7 Summons, # 8 Summons, # 9 Original Filing Form)(King, Douglas) (Entered: 08/25/2014)
08/25/20142 NOTICE OF PROCESS SERVER by Plaintiff Alternative Medicine and Pharmacy, Inc. Process Server: Amy R. Post (BAK) (Entered: 08/25/2014)
08/25/20143 DISCLOSURE OF CORPORATION INTERESTS CERTIFICATE by Plaintiff Alternative Medicine and Pharmacy, Inc.. Parent companies: None, Subsidiaries: None, Publicly held company: None,. (BAK) (Entered: 08/25/2014)
08/25/20144  MOTION for Temporary Restraining Order by Plaintiff Alternative Medicine and Pharmacy, Inc.. (King, Douglas) (Entered: 08/25/2014)
08/25/20145 MEMORANDUM in Support of Motion re 4 MOTION for Temporary Restraining Order filed by Plaintiff Alternative Medicine and Pharmacy, Inc.. (King, Douglas) (Entered: 08/25/2014)
08/25/2014 Case Opening Notification: 2 Summons(es) issued. The summons were emailed to attorney Douglas W. King. Judge Assigned: U.S. District Judge Charles A. Shaw. (BAK) (Entered: 08/25/2014)
08/25/20146  MOTION to Expedite Discovery by Plaintiff Alternative Medicine and Pharmacy, Inc.. (Attachments: # 1 Exhibit First Interrogatories, # 2 Exhibit First Document Requests, # 3 Exhibit First Requests for Admissions)(King, Douglas) (Entered: 08/25/2014)
08/25/2014 ***REMARK - Judge Shaw was assigned to case before Motion for Temorary Restraining Order was filed. New judge will be assigned and new summons issued. (BAK) (Entered: 08/25/2014)
08/25/2014 Case Opening Notification: 2 Summons(es) re-issued. The summons were emailed to attorney Douglas W. King. All corporate parties must file Disclosure of Corporate Interest form. The form can be found on the court website. Judge Assigned: U.S. District Judge Catherine D. Perry. Attorney contacted by both Lori Miller-Young and Beth Kirkland regarding filing of memorandum stating when hearing for TRO is to be held. (BAK) (Entered: 08/25/2014)
08/26/20147 ORDER: IT IS HEREBY ORDERED that the plaintiff's motions for a temporary restraining order [# 4 ] and to expedite discovery [# 6 ] are set for a hearing on Thursday, August 28, 2014 at 10:30 a.m. in Courtroom 14-South. (Motion Hearing set for 8/28/2014 10:30 AM in Courtroom 14S before District Judge Catherine D. Perry.) Signed by District Judge Catherine D. Perry on August 26, 2014. (BRP) (Entered: 08/26/2014)
08/27/20148  ENTRY of Appearance by Sarah C. Hellmann for Defendants Express Scripts, Inc., Medco Health Services, Inc.. (Hellmann, Sarah) (Entered: 08/27/2014)
08/27/20149  ENTRY of Appearance by Kyle P. Seelbach for Defendants Express Scripts, Inc., Medco Health Services, Inc.. (Seelbach, Kyle) (Entered: 08/27/2014)
08/27/201410 DISCLOSURE OF CORPORATION INTERESTS CERTIFICATE by Defendant Express Scripts, Inc... (Seelbach, Kyle) (Entered: 08/27/2014)
08/27/201411 DISCLOSURE OF CORPORATION INTERESTS CERTIFICATE by Defendant Medco Health Services, Inc... (Seelbach, Kyle) (Entered: 08/27/2014)
08/27/201412  MOTION to Continue Hearing on Plaintiff's Motion for Temporary Restraining Order and Expedited Discovery by Defendants Express Scripts, Inc., Medco Health Services, Inc.. (Seelbach, Kyle) (Entered: 08/27/2014)
08/27/201413 RESPONSE in Opposition re 12 MOTION to Continue Hearing on Plaintiff's Motion for Temporary Restraining Order and Expedited Discovery filed by Plaintiff Alternative Medicine and Pharmacy, Inc.. (King, Douglas) (Entered: 08/27/2014)
08/27/201414 Docket Text ORDER: Re: 12 MOTION to Continue Hearing ; ORDERED DENIED, hearing will go forward as previously scheduled unless parties jointly notify the court that they have agreed to a different schedule. Signed by District Judge Catherine D. Perry on 8/27/14. (CDP) (Entered: 08/27/2014)
08/27/2014 ***REMARK: Exhibits A, B, and C were placed under seal by the clerk at the request of plaintiff's counsel. Plaintiff's counsel advised the defendants have already been served with the documents. (BRP) (Entered: 08/28/2014)
08/28/201415 Minute Entry for proceedings held before District Judge Catherine D. Perry: Motion Hearing held on 8/28/2014 re 4 MOTION for Temporary Restraining Order filed by Alternative Medicine and Pharmacy, Inc.. Counsel inform the Court that they have reached an agreement. The Court and counsel discussed deadlines regarding Preliminary Injunction. Order to follow. (Court Reporter:G. Madden.) (FTR Gold: No.) (MCB) (Entered: 08/28/2014)